Clinical Trial Update: PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PR104 in patients with previously untreated or relapsed small cell lung cancer; the study (NCT00544674) conducted by Proacta w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• PR104

Snippet

Sponsor: Proacta, Incorporated | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-07-07